Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Dividends Score | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TNET | TRINET GROUP INC | $5.25B | 0.24% | 4.00% | $0.2500 | $0.25 | 3% | 0 | |||
| NGNE | NEUROGENE INC | $432.37M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $616.68M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| CPA | COPA HOLDINGS SA | $4.60B | 3.72% | 31.80% | $1.6100 | $4.07 | 67% | 3 | 2024-05-31 | 2024-06-14 | |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $1.41B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| GEF | GREIF INC | $3.01B | 3.22% | 34.90% | $0.5200 | $2.06 | 60% | 0 | |||
| APTO | APTOSE BIOSCIENCES INC | $19.25M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| ANNX | ANNEXON INC | $400.15M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| ACLS | AXCELIS TECHNOLOGIES INC | $3.68B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| DNTH | DIANTHUS THERAPEUTICS INC | $752.23M | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| APGE | APOGEE THERAPEUTICS INC | $2.94B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| SNDX | SYNDAX PHARMACEUTICALS INC | $1.72B | N/A | 0.00% | N/A | N/A | N/A | N/A | |||
| RRX | REGAL REXNORD CORP | $10.62B | 0.88% | -291.70% | $0.3500 | $1.40 | 16% | 1 | 2024-06-28 | 2024-07-12 | |
| IMVT | IMMUNOVANT INC | $4.46B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.